ABBV vs WST
By Alex · Tickerpine
AbbVie Inc. vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | WST |
|---|---|---|
| Price | $265.79 | $348.48 |
| Market cap | $469.68B | $24.52B |
| P/E ratio | 74.7 | 45.3 |
| ROE | — | 19.09% |
| Profit margin | 9.80% | 16.98% |
| Revenue growth | 10.20% | 13.80% |
| Dividend yield | 2.62% | 0.25% |
| Beta | 0.28 | 1.14 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs WST in plain English
- ABBV is the bigger company — about 19.2× the market cap of WST.
- WST is cheaper on earnings (P/E 45.3 vs 74.7).
- WST is growing revenue faster (14% vs 10%).
- ABBV has the higher dividend yield (2.62% vs 0.25%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.